chevron_leftBack
As of 8 June 2026, China Meheco Group Co., Ltd. has a market cap of $2.3B USD, ranking #6445 globally and #1499 in China.
It ranks #512 in the Healthcare sector, and #17 in the Drug Manufacturers - Specialty & Generic industry.
Key Stats
Market Cap
$2.3BUSD
15.56B CNY
Enterprise Value
$3.12BUSD
21.14B CNY
Revenue (TTM)
$5.17BUSD
35.02B CNY
EBITDA (TTM)
$261.99MUSD
1.77B CNY
Net Income (TTM)
$71.26MUSD
482.86M CNY
EBITDA Margin
5.1%
Profit Margin
1.4%
PE Ratio
32.2
PS Ratio
0.4
PB Ratio
1.1
EV/EBITDA
11.6
Company Profile
Country (HQ)
Sector
Healthcare
CEO
Huidong Hu
open_in_new
Employees
8,368
Founded
1983
Website
meheco.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.4% | -0.8% | 2.1% | -6.2% | -7.6% | 2.6% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
600056
中国医药健康产业股份有限公司 Class A
ISIN: CNE000000Q29
Shares Out.:
Shares Outstanding:
1.496B1
Shares Float:
696.432M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
10.36 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About China Meheco Group Co., Ltd.
China Meheco Group Co., Ltd. engages in the manufacture, marketing, and trade of pharmaceuticals and medical devices in China and internationally. The company is involved in the planting and sale of Chinese medicinal materials, as well as the provision of related technical and warehousing services. Its drug products cover therapeutic fields, such as anti-infection, cardiovascular, hormones and endocrine regulation, respiratory and digestive systems, nutritional supplements, antipyretic analgesics, and other therapeutic areas as well as Chinese herbal medicine processing and decoction pieces. The company was founded in 1983 and is based in Beijing, China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SHE: 002001
|
$15.84B
590%
107.34B CNY
|
16.0
|
|
SHE: 002653
|
$9.09B
296%
61.6B CNY
|
80.6
|
|
SHE: 000423
|
$5.21B
127%
35.33B CNY
|
20.0
|
|
SHE: 002603
|
$4.2B
83%
28.47B CNY
|
20.8
|
|
SHE: 000623
|
$3.26B
42%
22.12B CNY
|
8.1
|
|
|
$2.74B
19%
18.55B CNY
|
11.5
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TLV: TEVA
|
$37.17B
2K%
108.92B ILS
|
24.2
|
|
NASDAQ: RVMD
|
$29.56B
1K%
|
-
|
|
NSE: CIPLA
|
$11.16B
386%
1.06T INR
|
23.4
|
|
NSE: LUPIN
|
$11.04B
381%
1.05T INR
|
22.7
|
|
EPA: ABVX
|
$8.72B
280%
7.57B EUR
|
-
|
|
NSE: AUROPHARMA
|
$8.46B
269%
807.02B INR
|
23.1
|
chevron_leftBack